| Response . | Patients, n (%) (n = 37) . |
|---|---|
| Overall response | 29 (78) |
| Complete response | 4 (11) |
| Partial response | 25 (68) |
| Stable disease | 4 (11) |
| Progressive disease | 4 (11) |
| Response . | Patients, n (%) (n = 37) . |
|---|---|
| Overall response | 29 (78) |
| Complete response | 4 (11) |
| Partial response | 25 (68) |
| Stable disease | 4 (11) |
| Progressive disease | 4 (11) |
| Response . | Patients, n (%) (n = 37) . |
|---|---|
| Overall response | 29 (78) |
| Complete response | 4 (11) |
| Partial response | 25 (68) |
| Stable disease | 4 (11) |
| Progressive disease | 4 (11) |
| Response . | Patients, n (%) (n = 37) . |
|---|---|
| Overall response | 29 (78) |
| Complete response | 4 (11) |
| Partial response | 25 (68) |
| Stable disease | 4 (11) |
| Progressive disease | 4 (11) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
